Feedback PLC Notice of Results & Investor Presentation
11 Février 2025 - 8:00AM
RNS Regulatory News
RNS Number : 5435W
Feedback PLC
11 February 2025
Feedback plc
Notice of Results & Investor
Presentation
Feedback plc (AIM: FDBK, "Feedback"
or the "Company"), the clinical infrastructure specialist,
expects to announce results for the half year
ended 30 November 2024 on Tuesday 25 February
2025.
Analyst Presentation: 09:30, Tuesday 25
February
A remote briefing for analysts will
be held at 09:30 on the morning of the results. Analysts
interested in attending should contact Walbrook PR
on feedbackplc@walbrookpr.com or 020 7933
8780.
Investor Presentation: 16:00, Tuesday 25
February
Management will be providing a
presentation and hosting an investor Q&A session on the
Company's results and future prospects on Tuesday 25 February at
16:00. Investors can sign up for free and register to meet FDBK via
the following link:
https://www.investormeetcompany.com/feedback-plc/register-investor
Investors who have already registered
on the Investor Meet Company platform to meet the Company will
automatically be invited.
-Ends-
Enquiries:
Feedback plc
Tom Oakley, CEO
Anesh Patel, CFO
|
+44 (0) 20 3997 7634
IR@fbk.com
|
|
|
Panmure Liberum Limited (NOMAD and Broker)
Emma Earl/Mark Rogers (Corporate
Finance)
Rupert Dearden (Corporate
Broking)
|
+44 (0)20 7886 2500
|
|
|
Walbrook PR Ltd
|
Tel: 020 7933 8780 or
feedbackplc@walbrookpr.com
|
Nick Rome/Joe Walker
|
07748 325 236 or 07407 020
470
|
About Feedback
Feedback plc helps clinical teams to
make better decisions faster for patients. We design products that
enhance clinician access to patient data and to their colleagues.
Our unique approach centres around individual patient episodes,
into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a
result, we produce a digital infrastructure that makes patient data
available to clinicians in multiple settings, in a format that
enables them to meaningfully interact with it, providing
flexibility to clinicians and free movement of patients between
provider settings - clinicians can practice from anywhere and
patients can attend any care provider for treatment, with greater
connectivity across organisations.
Our products Bleepa® and CareLocker®
work together to deliver unparalleled value to our customers.
Bleepa® is our application layer and sits on top of CareLocker® as
our data layer. Bleepa® is a clinician facing platform that
displays clinical results from a patient's CareLocker® at a
certified and regulated quality, that is suitable for clinical use
and enables dialogue on a patient-by-patient basis with colleagues
through a secure, auditable chat interface that links back to the
patient medical record. The CareLocker® data storage model is built
around the patient. Our vision is one where relevant clinical data
is always available to the patient as well as to any care setting
that they may attend - a federated data architecture with the
patient as the tenant.
The Company has a number of growth
opportunities domestically and internationally across a range of
markets including the NHS and private healthcare providers and its
highly scalable Software as a Service ("SaaS")-based model is
expected to provide increasing levels of revenue visibility as the
Company grows its customer base.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NORFLFILFSIILIE
Feedback (LSE:FDBK)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Feedback (LSE:FDBK)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025